SCHEMBL23488274

SCHEMBL23488274

COc1cc(OCc2ccccc2)ccc1C(=O)OC[C@H]1O[C@@H](OC)[C@H](O)[C@@H](O)[C@@H]1O

nearest known ligand 0.49

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.49
SLC5A1 P13866 2/20 0.43
SLC5A2 P31639 2/20 0.43
PARP15 Q460N3 1/20 0.42
TYMP P19971 1/20 0.42
MAOB P27338 2/20 0.42
XDH P47989 2/20 0.42
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
LGALS8 O00214 1/20 0.41
OXTR P30559 1/20 0.41
NPC1 O15118 2/20 0.40
RAB9A P51151 2/20 0.40
KDM4E B2RXH2 1/20 0.40
GAA P10253 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
APP P05067 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488464 0.90 MAOB (0.43) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488550 0.90 MAOB (0.43) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488472 0.88 MAOB (0.43) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488302 0.85 TDP1 (0.46) TDP1SLC5A1SLC5A2TYMPXDH
SCHEMBL23488262 0.84 CHRNB2 (0.51) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488668 0.84 CHRNB2 (0.51) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488128 0.84 CHRNB2 (0.51) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488442 0.83 TYMP (0.49) TDP1SLC5A1SLC5A2TYMPLGALS8
SCHEMBL23488297 0.83 TDP1 (0.48) TDP1SLC5A1SLC5A2TYMPMAOB
SCHEMBL23488164 0.82 TDP1 (0.52) TDP1TYMPXDHMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 TDP1 4093/4885SLC5A1 9/4885SLC5A2 10/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.